ong-term effects of voglibose on diabetic complication in Japanese patients with type 2 diabetes mellitus: a double-blind, randomized, placebo-controlled clinical trial
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000001111
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 550
Inclusion Criteria
Not provided
Exclusion Criteria
1) Those who are not allowed mydriasis due to glaucoma etc. 2) History of photocoagulation 3) Those who are inable to evaluate diabetic retinopathy due to internal ophthalmic surgery, corneal diseases or cataract etc. 4) Those who experienced a cerebrovascular event during the run-in period. 5) Those who experienced a significant ECG abnormality, significant cardiac diseases (myocardial infarction or angina pectoris) or arteriosclerosis obliterans (skin ulcer, gangrene or intermittent claudication) during the run-in period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The development or progression of diabetic retinopathy and/or nephropathy.
- Secondary Outcome Measures
Name Time Method